About PathoscribeAI
We are a team of AI experts and scientists applying advanced computational methods to solve critical challenges in pharmaceutical discovery and development.
Our Story
Founded in February 2025, PathoscribeAI was started by a group of AI specialists with a shared, strong interest in healthcare. Our founding principle was simple: advanced computation could dramatically improve and accelerate the long, costly process of drug development.
Our team combines deep expertise in machine learning, computational biology, and software engineering to build our intelligent platform. This system is designed to analyze complex datasets—from molecular structures to clinical trial results—to identify promising therapeutic candidates and novel biological targets.
We are driven by the challenge of applying technology to solve complex medical problems, both by finding new uses for existing medicines and by discovering new molecules for the treatments of the future.
Our Mission
Our core mission is to accelerate therapeutic discovery. We utilize advanced AI for both de novo drug design and high-throughput screening of repurposed compounds, aiming to shorten the R&D lifecycle and enhance preclinical success rates.
Accelerate R&D Timelines
Reduce Development Costs
Improve Patient Outcomes
By applying in-silico analysis to complex biological data, we help pharmaceutical partners optimize their development pipelines and unlock the full potential of their molecular data assets.
Our Vision
We envision a future where AI-driven pharmacology is the standard, fostering an ecosystem of rapid innovation that expands the global therapeutic arsenal and streamlines the path from lab to clinic.
Lead in AI-Pharma Innovation
Address Unmet Medical Needs
Transform Healthcare Delivery
Our goal is to become the global leader in AI-powered drug discovery, playing a pivotal role in tackling critical diseases and fundamentally improving health outcomes for patients worldwide.
Our Journey
Key milestones that have shaped our progress and defined our path forward.
Our company timeline is currently being updated. Please check back soon.
Certifications & Accreditations
We are committed to the highest standards of quality, security, and compliance.
Our certifications are currently being updated. Please check back soon.
Meet Our Team
Our team's strength lies in its expertise across artificial intelligence and biomedical science.
Pratap Singha
Founder & CTO
As the Founder and CTO of PathoscribeAI, Pratap Singha is pioneering the application of cutting-edge artificial intelligence to revolutionize pharmaceutical research. He architected the company's core technology, driving the development of the Drug Discovery AI Agent and Drug Repurposing AI Agent. Pratap leads with a deep focus on AI, ML, and Healthcare Innovation, ensuring that complex computer vision and NLP models translate directly into faster, more efficient pathways for life-saving therapeutic development.
AI
ML
Healthcare Innovation
Computer Vision
NLP
Ashutosh Rout
Co-Founder & CEO
As Co-Founder and CEO of PathoscribeAI, Ashutosh Rout leverages his technical background to translate the company’s advanced AI research into scalable commercial solutions. He is responsible for corporate strategy, market penetration, and strategic partnerships that bring the Drug Discovery AI Agents to market. Ashutosh ensures operational excellence, driving the adoption of PathoscribeAI's innovations to make a measurable impact on global healthcare.
Soumya Ranjan Acharya
Co-Founder & COO
As Co-Founder and COO, Soumya Ranjan Acharya ensures the flawless execution and scaling of PathoscribeAI's technological operations. Leveraging his technical foundation, he is responsible for managing the intricate data pipelines, infrastructure, and operational efficiency required to power the Drug Discovery AI Agents. Soumya’s focus is on maintaining high data integrity and streamlining processes to accelerate research cycles and deliver consistent, reliable therapeutic insights.